Open

Do GLP-1 receptor agonists improve cardiovascular events more than other treatments?

Also asked versus placebo.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Unlikely. So far, the results disagree.

NoUnsureYes
Belief
0.00 (range 0.00–0.55)
Trials for
0
Trials against
3
Inconclusive
0

Already under way

No registered trial that could settle this is recruiting or active.

The evidence so far

Registered trials
102
With posted results
44
Published papers
33

Of 61 decided analyses: 19 favor glp-1 receptor agonists, 34 find no difference, 8 favor the comparator.

Papers

Trials

See every trial in the evidence map →